• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低自付费用与药物依从性——一项基于人群的研究。

Reduced Out-of-Pocket Costs and Medication Adherence - A Population-Based Study.

作者信息

Yao Shenzhen, Lix Lisa, Shevchuk Yvonne, Teare Gary, Blackburn David F

机构信息

University of Saskatchewan.

University of Manitoba.

出版信息

J Popul Ther Clin Pharmacol. 2018 Jan 15;25(1):e1-e17. doi: 10.22374/1710-6222.25.1.1.

DOI:10.22374/1710-6222.25.1.1
PMID:29949684
Abstract

BACKGROUND

In 2007, a drug benefit plan for Seniors (SDP) was launched in Saskatchewan, Canada. SDP capped out-of-pocket costs at $15 per prescription for individuals aged 65 and older.

OBJECTIVES

To quantify the impact of the SDP on chronic medication adherence.  Methods: A retrospective cohort study was conducted for participants aged 65 or older who were eligible to the SPD, controlled by a younger group aged 40 to 64 who were ineligible. Adherence was measured over 365 days using medication possession ratio (MPR). MPRs were compared between age groups, and between pre and post SDP-launch periods. The odds ratio of optimal adherence (i.e., MPR≥80%) was estimated using logistic regression models with generalized estimating equations (GEE).

RESULTS

Between 2005 and 2009, 353,568 adherence observations were observed from 188,109 unique patients. Comparing the post-SDP period vs before, the increase in the odds of optimal medication adherence was significant (OR=1.08, 95% CI: 1.04 to 1.11) and was stronger after excluding patients already receiving medication benefits from other government programs (OR= 1.21, 95% CI: 1.16 to 1.26). The SDP was associated with improved adherence among the subgroup of prevalent medication users (OR=1.08, 95% CI: 1.04 to 1.12), but not incident users (OR=1.05, 95% CI: 0.98 to 1.13).

CONCLUSION

Reducing out-of-pocket medication costs for seniors was associated with small improvements in medication adherence across the population.

摘要

背景

2007年,加拿大萨斯喀彻温省推出了一项老年人药物福利计划(SDP)。SDP为65岁及以上的个人设定了每次处方自付费用上限为15加元。

目的

量化SDP对慢性药物依从性的影响。方法:对符合SDP资格的65岁及以上参与者进行回顾性队列研究,由不符合资格的40至64岁较年轻组进行对照。使用药物持有率(MPR)在365天内测量依从性。比较年龄组之间以及SDP推出前后的MPR。使用带有广义估计方程(GEE)的逻辑回归模型估计最佳依从性(即MPR≥80%)的优势比。

结果

2005年至2009年期间,从188,109名独特患者中观察到353,568次依从性观察。将SDP实施后时期与之前进行比较,最佳药物依从性的优势比增加显著(OR = 1.08,95% CI:1.04至1.11),在排除已从其他政府计划获得药物福利的患者后更强(OR = 1.21,95% CI:1.16至1.26)。SDP与现有药物使用者亚组中依从性的改善相关(OR = 1.08,95% CI:1.04至1.12),但与新使用者无关(OR = 1.05,95% CI:0.98至1.13)。

结论

降低老年人的自付药物费用与总体人群药物依从性的小幅改善相关。

相似文献

1
Reduced Out-of-Pocket Costs and Medication Adherence - A Population-Based Study.降低自付费用与药物依从性——一项基于人群的研究。
J Popul Ther Clin Pharmacol. 2018 Jan 15;25(1):e1-e17. doi: 10.22374/1710-6222.25.1.1.
2
Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.私人药品保险计划覆盖的患者的报销时间和自付费用对药物依从性的影响。
J Manag Care Spec Pharm. 2016 May;22(5):539-47. doi: 10.18553/jmcp.2016.22.5.539.
3
Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.向更具限制性的药品处方集转变对治疗中断和药物依从性的影响。
J Clin Pharm Ther. 2016 Feb;41(1):64-9. doi: 10.1111/jcpt.12349. Epub 2016 Jan 18.
4
Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.费用对无法获得处方药物的影响:以他汀类药物为例。
Appl Health Econ Health Policy. 2017 Oct;15(5):625-634. doi: 10.1007/s40258-017-0336-8.
5
Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.美国和加拿大与费用相关的处方不依从性:使用2007年七国国际卫生政策调查进行的系统层面比较。
Clin Ther. 2009 Jan;31(1):213-9. doi: 10.1016/j.clinthera.2009.01.006.
6
Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost.评估美国医疗补助计划中强化预先授权和管理计划对慢性丙型肝炎治疗依从性和成本的影响。
J Am Pharm Assoc (2003). 2018 Sep-Oct;58(5):485-491. doi: 10.1016/j.japh.2018.06.013. Epub 2018 Jul 19.
7
Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.痤疮患者接受医疗补助计划覆盖的痤疮药物治疗的药物依从性、医疗费用和利用情况。
Am J Clin Dermatol. 2013 Jun;14(3):243-51. doi: 10.1007/s40257-013-0016-x.
8
Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.德克萨斯州医疗补助受助者中,抗糖尿病固定剂量复方制剂与双联疗法相比的患者依从性和报销金额。
Clin Ther. 2008 Oct;30(10):1893-907. doi: 10.1016/j.clinthera.2008.10.003.
9
Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.2型糖尿病药物费用分担对患者治疗结果和健康计划成本的影响。
Am J Manag Care. 2016 Jun;22(6):433-40.
10
Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.年度美元限额或“上限”对医疗保险患者处方药福利的影响。
JAMA. 2003 Jul 9;290(2):222-7. doi: 10.1001/jama.290.2.222.

引用本文的文献

1
Treating hypertension with single pill combinations: a simple strategy to save costs for the patients and payers.使用单片复方制剂治疗高血压:一种为患者和支付方节省成本的简单策略。
J Hypertens. 2025 Sep 1;43(9):1478-1484. doi: 10.1097/HJH.0000000000004050. Epub 2025 Jun 16.
2
The Association Between Type of Insurance Plan, Out-of-Pocket Cost, and Adherence to Antihypertensive Medications in Medicare Supplement Insurance Enrollees.医疗保险计划类型、自付费用与医疗保险补充计划参保者抗高血压药物治疗依从性之间的关系。
Am J Hypertens. 2024 Jul 15;37(8):631-639. doi: 10.1093/ajh/hpae062.
3
Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact.
加拿大与费用相关的药物治疗不依从性:患病率、预测因素及临床影响的系统评价
Syst Rev. 2021 Jan 6;10(1):11. doi: 10.1186/s13643-020-01558-5.
4
Cost-related nonadherence to prescription medications in Canada: a scoping review.加拿大与费用相关的处方药治疗不依从性:一项范围综述
Patient Prefer Adherence. 2018 Sep 6;12:1699-1715. doi: 10.2147/PPA.S170417. eCollection 2018.